Atossa Therapeutics, Inc. (ATOS)
4.40
-0.01
(-0.23%)
USD |
NASDAQ |
Jun 10, 16:00
4.40
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Market Cap : 37.89M for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 37.89M |
| June 09, 2026 | 37.98M |
| June 08, 2026 | 39.18M |
| June 05, 2026 | 38.49M |
| June 04, 2026 | 41.77M |
| June 03, 2026 | 40.47M |
| June 02, 2026 | 41.77M |
| June 01, 2026 | 44.00M |
| May 29, 2026 | 45.04M |
| May 28, 2026 | 44.69M |
| May 27, 2026 | 44.09M |
| May 26, 2026 | 42.63M |
| May 22, 2026 | 42.71M |
| May 21, 2026 | 42.80M |
| May 20, 2026 | 41.68M |
| May 19, 2026 | 40.86M |
| May 18, 2026 | 41.16M |
| May 15, 2026 | 41.77M |
| May 14, 2026 | 44.35M |
| May 13, 2026 | 44.43M |
| May 12, 2026 | 44.43M |
| May 11, 2026 | 47.36M |
| May 08, 2026 | 48.22M |
| May 07, 2026 | 48.83M |
| May 06, 2026 | 49.95M |
| Date | Value |
|---|---|
| May 05, 2026 | 48.05M |
| May 04, 2026 | 50.46M |
| May 01, 2026 | 45.90M |
| April 30, 2026 | 46.24M |
| April 29, 2026 | 45.47M |
| April 28, 2026 | 47.28M |
| April 27, 2026 | 46.93M |
| April 24, 2026 | 49.08M |
| April 23, 2026 | 49.34M |
| April 22, 2026 | 51.24M |
| April 21, 2026 | 49.69M |
| April 20, 2026 | 53.13M |
| April 17, 2026 | 50.20M |
| April 16, 2026 | 49.69M |
| April 15, 2026 | 49.43M |
| April 14, 2026 | 46.07M |
| April 13, 2026 | 45.73M |
| April 10, 2026 | 42.54M |
| April 09, 2026 | 42.88M |
| April 08, 2026 | 41.51M |
| April 07, 2026 | 42.02M |
| April 06, 2026 | 44.35M |
| April 02, 2026 | 46.20M |
| April 01, 2026 | 44.00M |
| March 31, 2026 | 45.30M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sensei Biotherapeutics, Inc. | 14.39M |
| ACADIA Pharmaceuticals, Inc. | 3.636B |
| Alnylam Pharmaceuticals, Inc. | 38.86B |
| Savara, Inc. | 1.043B |
| Vericel Corp. | 1.907B |
Market Cap Related Metrics
| PEG Ratio | -0.0026 |
| Price to Book Value | 1.243 |
| Price | 4.40 |
| Earnings Yield | -99.31% |
| PEGY Ratio | -0.0026 |